Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Short-Term Debt issuances (2024)

bioAffinity Technologies (BIAF) has disclosed Short-Term Debt issuances for 1 consecutive years, with -$96911.0 as the latest value for Q4 2024.

  • On a quarterly basis, Short-Term Debt issuances changed N/A to -$96911.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $191849.0, a N/A change, with the full-year FY2024 number at $191849.0, up 176.21% from a year prior.
  • Short-Term Debt issuances was -$96911.0 for Q4 2024 at bioAffinity Technologies, down from $261888.0 in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $261888.0 in Q3 2024 to a low of -$96911.0 in Q4 2024.